Lack of Relationships Between Ketamine Treatment and Peripheral Neurotrophic and Inflammatory Factors in a Randomized Controlled Ketamine Trial of Major Depressive Disorder

Authors

Manivel Rengasamy
Benjamin Panny
Zakary Hutchinson
Anna Marsland
Tessa Kovats
Angela Griffo
Crystal Spotts
Robert H Howland
Meredith L Wallace
Sanjay J Mathew
Shabnam Hossein
Rebecca B Price

Language

English

Publication Date

8-1-2025

Journal

Brain, Behavior, and Immunity

DOI

10.1016/j.bbi.2025.04.006

PMID

40188855

PubMedCentral® Full Text Version

Post-print

Abstract

Background: Ketamine is a rapid-acting treatment for treatment-resistant depression (TRD), though mechanisms related to ketamine's effects remain unclear. Blood-based neurotrophic and inflammatory factors (NIFs; e.g., brain-derived neurotrophic factor, interleukin-6) have emerged as markers potentially linked to ketamine and ketamine treatment response.

Methods: In this secondary analysis of a randomized controlled trial (RCT), 133 adults with TRD received a single-dose infusion of ketamine (n = 89; 0.5 mg/kg) or saline (n = 44) and provided measures of peripheral blood NIF levels and depression severity across a five-day post-infusion period. Differences between ketamine and saline groups were examined for (1) NIF levels, (2) associations between NIF trajectories and depression score trajectories, and (3) associations between baseline NIF levels and depression score trajectories. Subgroup sensitivity analyses examined identical relationships within many (n = 28) discrete subgroups of individuals.

Results: No differences were found between ketamine and saline cohorts for NIF trajectories, associations of NIF and depression trajectories, or associations of baseline NIF levels and depression trajectories. On subgroup analyses, in participants with lower BMI (BMI < 25; n = 66), increasing interleukin-1 receptor antagonist (IL-1RA) trajectories post-ketamine were associated with less improvement in depression in the first day post-infusion.

Discussion: Associations between ketamine treatment and peripheral neurotrophic/inflammatory factors were not detected in our RCT of 133 adults with TRD. The sole exception across exhaustive sensitivity analyses was that, in individuals with low BMI, increases in IL-1RA levels may be linked to worse immediate treatment response. Future research investigating CNS-specific NIF activity is needed to more definitively test the posited role of NIFs in ketamine's antidepressant mechanisms.

Keywords

Humans, Ketamine, Female, Male, Adult, Depressive Disorder, Major, Middle Aged, Brain-Derived Neurotrophic Factor, Depressive Disorder, Treatment-Resistant, Antidepressive Agents, Interleukin-6, Treatment Outcome, Inflammation, Antidepressant, BDNF, Cytokines, Inflammation, Ketamine, RCT, Treatment

Published Open-Access

yes

Recommended Citation

Rengasamy, Manivel; Panny, Benjamin; Hutchinson, Zakary; et al., "Lack of Relationships Between Ketamine Treatment and Peripheral Neurotrophic and Inflammatory Factors in a Randomized Controlled Ketamine Trial of Major Depressive Disorder" (2025). Staff and Researcher Publications. 44.
https://digitalcommons.library.tmc.edu/clinic_pub/44